News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Avastin Likely Will be Approved for Ovarian Cancer, Roche Holding AG (RHHBF.PK) Says


5/27/2011 7:53:01 AM

Roche Holding AG, the world's leader in oncology drugs, struck an upbeat tone about approval prospects for its key drug Avastin in ovarian cancer ahead of an important industry meeting next month.

The group's pharma head Pascal Soriot told reporters on Thursday he was confident Avastin will gain European approval and he was also relatively optimistic about winning U.S. backing for the drug.


Read at Reuters
Read at Market Watch

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES